One of challenges  we had to tackle this year for one our customers, The Maastricht Study, was building a Data Download Portal for tranSMART. TranSMART allows you to export all the data just fine by itself, so you might ask why would you need a[…]

The Hyve, together with Proventa International, organized its first Innovation Spotlight Session on Open Source Technologies for Precision Medicine. We were honored with a great attendance from industry and academia and were happy to see new ideas[…]

During the TranSMART architectural workshop we have discussed the future of TranSMART from a developer perspective. We focussed on creating a solid but flexible, maintainable architecture on which we can build new features without losing too much[…]

On a nice spring evening Tim and I flew to Copenhagen to meet up with the people of Gritsystems. Together we form the technical heart of the implementation team of the ND4BB InfoCenter (a repository for preclinical and clinical data to facilitate[…]

The cBioPortal for Cancer Genomics is a well known, and well loved, interface for interactive analysis of cancer data. It has been developed, maintained and is also heavily used by the Memorial Sloan Kettering Cancer Center in New York.

New scientific discoveries increasingly rely on the integration of data from different types of experiments. The Hyve has extensive experience with using the open source tranSMART platform for the storage and analysis of this multi-omics data.

The TranSMART community has been growing at a very rapid pace. It’s seen more success in the last two years than its creators at J&J and Recombinant would have imagined in 2012. In this article, I would like to lay out some perspectives on where[…]

The Hyve has active collaborations with several academic groups in The Netherlands. On 24 and 25 March, we organized a joint workshop with the Molgenis team from UMC Groningen (led by Morris Swertz). We collaborate with Molgenis, amongst others, in[…]

With the recent 'TranSMART 2.0 Architecture Workshop', organized at our The Hyve offices in Utrecht, the basis has been laid for the next phase of tranSMART. The goals for the workshop were formulated as:

When tranSMART was conceived originally by Recombinant at Johnson & Johnson, it was supposed to extend the clinical warehouse I2B2 with biomarker data, such as microarray gene expression data, and allow the both datatypes to be integrated. TranSMART[…]